123 related articles for article (PubMed ID: 38142230)
41. MRI of occult breast carcinoma in a high-risk population.
Morris EA; Liberman L; Ballon DJ; Robson M; Abramson AF; Heerdt A; Dershaw DD
AJR Am J Roentgenol; 2003 Sep; 181(3):619-26. PubMed ID: 12933450
[TBL] [Abstract][Full Text] [Related]
42. Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study.
Román M; Rué M; Sala M; Ascunce N; Baré M; Baroja A; De la Vega M; Galcerán J; Natal C; Salas D; Sánchez-Jacob M; Zubizarreta R; Castells X;
PLoS One; 2013; 8(12):e83121. PubMed ID: 24376649
[TBL] [Abstract][Full Text] [Related]
43. No impact of breast magnetic resonance imaging on 15-year outcomes in patients with ductal carcinoma in situ or early-stage invasive breast cancer managed with breast conservation therapy.
Vapiwala N; Hwang WT; Kushner CJ; Schnall MD; Freedman GM; Solin LJ
Cancer; 2017 Apr; 123(8):1324-1332. PubMed ID: 27984658
[TBL] [Abstract][Full Text] [Related]
44. Screening magnetic resonance imaging recommendations and outcomes in patients at high risk for breast cancer.
Ehsani S; Strigel RM; Pettke E; Wilke L; Tevaarwerk AJ; DeMartini WB; Wisinski KB
Breast J; 2015; 21(3):246-53. PubMed ID: 25789917
[TBL] [Abstract][Full Text] [Related]
45. Outcomes Following Negative Screening MRI Results in Korean Women with a Personal History of Breast Cancer: Implications for the Next MRI Interval.
Park VY; Kim MJ; Kim GR; Yoon JH
Radiology; 2021 Aug; 300(2):303-311. PubMed ID: 34032514
[TBL] [Abstract][Full Text] [Related]
46. Breast MRI screening of women with a personal history of breast cancer.
Brennan S; Liberman L; Dershaw DD; Morris E
AJR Am J Roentgenol; 2010 Aug; 195(2):510-6. PubMed ID: 20651211
[TBL] [Abstract][Full Text] [Related]
47. Outcomes of multimodality breast screening for women at increased risk of familial breast cancer.
Bennett IC; Muller J; Cockburn L; Joshua H; Thorley G; Baker C; Wood N; Brazier J; Jones M; Dunn N; Gattas M
World J Surg; 2010 May; 34(5):979-86. PubMed ID: 20108093
[TBL] [Abstract][Full Text] [Related]
48. Computer-aided evaluation as an adjunct to revised BI-RADS Atlas: improvement in positive predictive value at screening breast MRI.
Gweon HM; Cho N; Seo M; Chu AJ; Moon WK
Eur Radiol; 2014 Aug; 24(8):1800-7. PubMed ID: 24788228
[TBL] [Abstract][Full Text] [Related]
49. The Effect of Prior Comparison MRI on Interpretive Performance of Screening Breast MRI.
Burk KS; Edmonds CE; Mercaldo SF; Lehman CD; Sippo DA
J Breast Imaging; 2020 Feb; 2(1):36-42. PubMed ID: 38425000
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of a known breast cancer using an abbreviated breast MRI protocol: Correlation of imaging characteristics and pathology with lesion detection and conspicuity.
Heacock L; Melsaether AN; Heller SL; Gao Y; Pysarenko KM; Babb JS; Kim SG; Moy L
Eur J Radiol; 2016 Apr; 85(4):815-23. PubMed ID: 26971429
[TBL] [Abstract][Full Text] [Related]
51. Comparison between breast MRI and contrast-enhanced spectral mammography.
Łuczyńska E; Heinze-Paluchowska S; Hendrick E; Dyczek S; Ryś J; Herman K; Blecharz P; Jakubowicz J
Med Sci Monit; 2015 May; 21():1358-67. PubMed ID: 25963880
[TBL] [Abstract][Full Text] [Related]
52. Added Value of Breast MRI for Preoperative Diagnosis of Ductal Carcinoma In Situ: Diagnostic Performance on 362 Patients.
Petrillo A; Fusco R; Petrillo M; Triunfo F; Filice S; Vallone P; Setola SV; Rubulotta M; Di Bonito M; Rinaldo M; D'Aiuto M; Brunetti A
Clin Breast Cancer; 2017 Jun; 17(3):e127-e134. PubMed ID: 28111130
[TBL] [Abstract][Full Text] [Related]
53. Screening MRI in Women With a Personal History of Breast Cancer.
Lehman CD; Lee JM; DeMartini WB; Hippe DS; Rendi MH; Kalish G; Porter P; Gralow J; Partridge SC
J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26744477
[TBL] [Abstract][Full Text] [Related]
54. Semiannual Breast US or MRI Screening in Patients with a Personal History of Breast Cancer.
Ha SM; Lee JM; Kim SO; Moon WK; Chang JM
Radiology; 2023 Jun; 307(5):e221660. PubMed ID: 37158719
[TBL] [Abstract][Full Text] [Related]
55. Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer.
Buist DSM; Abraham L; Lee CI; Lee JM; Lehman C; O'Meara ES; Stout NK; Henderson LM; Hill D; Wernli KJ; Haas JS; Tosteson ANA; Kerlikowske K; Onega T;
JAMA Intern Med; 2018 Apr; 178(4):458-468. PubMed ID: 29435556
[TBL] [Abstract][Full Text] [Related]
56. An Abbreviated Protocol for High-risk Screening Breast Magnetic Resonance Imaging: Impact on Performance Metrics and BI-RADS Assessment.
Panigrahi B; Mullen L; Falomo E; Panigrahi B; Harvey S
Acad Radiol; 2017 Sep; 24(9):1132-1138. PubMed ID: 28506511
[TBL] [Abstract][Full Text] [Related]
57. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
[TBL] [Abstract][Full Text] [Related]
58. Outcome of breast cancer screening in Denmark.
Lynge E; Bak M; von Euler-Chelpin M; Kroman N; Lernevall A; Mogensen NB; Schwartz W; Wronecki AJ; Vejborg I
BMC Cancer; 2017 Dec; 17(1):897. PubMed ID: 29282034
[TBL] [Abstract][Full Text] [Related]
59. High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer.
Bick U; Engel C; Krug B; Heindel W; Fallenberg EM; Rhiem K; Maintz D; Golatta M; Speiser D; Rjosk-Dendorfer D; Lämmer-Skarke I; Dietzel F; Schäfer KWF; Leinert E; Weigel S; Sauer S; Pertschy S; Hofmockel T; Hagert-Winkler A; Kast K; Quante A; Meindl A; Kiechle M; Loeffler M; Schmutzler RK;
Breast Cancer Res Treat; 2019 May; 175(1):217-228. PubMed ID: 30725383
[TBL] [Abstract][Full Text] [Related]
60. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
